SCHEMBL27599861

SCHEMBL27599861

C[C](C)Cc1nc(Cl)cc2ccccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.40
ADORA3 P0DMS8 1/20 0.38
NQO2 P16083 1/20 0.36
KDM4E B2RXH2 2/20 0.36
AHR P35869 2/20 0.35
USP2 O75604 1/20 0.35
HTT P42858 1/20 0.35
MAPT P10636 5/20 0.35
ALDH1A1 P00352 4/20 0.35
NPC1 O15118 1/20 0.35
NR1I2 O75469 1/20 0.34
LMNA P02545 1/20 0.34
HPGD P15428 2/20 0.34
KMT2A Q03164 3/20 0.34
CYP2C19 P33261 2/20 0.34
GAA P10253 2/20 0.34
MEN1 O00255 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16516540 0.80 L3MBTL1 (0.44) L3MBTL1NQO2KDM4EMAPTALDH1A1
SCHEMBL16008667 0.80 L3MBTL1 (0.44) L3MBTL1ADORA3NQO2KDM4EUSP2
SCHEMBL2990475 0.80 ADORA3 (0.42) L3MBTL1ADORA3KDM4EUSP2HTT
SCHEMBL2212160 0.79 ACACB (0.41) L3MBTL1ADORA3NQO2KDM4EHTT
SCHEMBL2215224 0.77 ALDH1A1 (0.51) L3MBTL1KDM4EAHRHTTMAPT
SCHEMBL28328752 0.77 L3MBTL1 (0.44) L3MBTL1NQO2KDM4EUSP2HTT
SCHEMBL28327541 0.77 HTR2A (0.48) L3MBTL1NQO2KDM4EMAPTALDH1A1
SCHEMBL14693670 0.77 L3MBTL1 (0.44) L3MBTL1ADORA3NQO2KDM4EHTT
SCHEMBL27529060 0.75 RAD52 (0.44) L3MBTL1KDM4EHTTMAPTALDH1A1
SCHEMBL10527114 0.72 L3MBTL1 (0.40) L3MBTL1NQO2KDM4EMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100351251-C Indolylmaleimide derivatives NOVARTIS AG (CH) 2007-11-28 CN disclosed
CN-1639153-A Indolylmaleimide derivatives NOVARTIS AG (CH) 2005-07-13 CN disclosed